ATE302413T1 - Schnelle bestimmung des verhältnisses von biologischen molekülen - Google Patents

Schnelle bestimmung des verhältnisses von biologischen molekülen

Info

Publication number
ATE302413T1
ATE302413T1 AT98923421T AT98923421T ATE302413T1 AT E302413 T1 ATE302413 T1 AT E302413T1 AT 98923421 T AT98923421 T AT 98923421T AT 98923421 T AT98923421 T AT 98923421T AT E302413 T1 ATE302413 T1 AT E302413T1
Authority
AT
Austria
Prior art keywords
ratio
biological molecules
rapid determination
relates
rapidly determining
Prior art date
Application number
AT98923421T
Other languages
English (en)
Inventor
Kenneth F Buechler
Original Assignee
Biosite Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosite Diagnostics Inc filed Critical Biosite Diagnostics Inc
Application granted granted Critical
Publication of ATE302413T1 publication Critical patent/ATE302413T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G01N33/723—Glycosylated haemoglobin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4712—Muscle proteins, e.g. myosin, actin, protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70546—Integrin superfamily, e.g. VLAs, leuCAM, GPIIb/GPIIIa, LPAM
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/7056—Selectin superfamily, e.g. LAM-1, GlyCAM, ELAM-1, PADGEM
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/795—Porphyrin- or corrin-ring-containing peptides
    • G01N2333/805—Haemoglobins; Myoglobins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/822—Identified hapten
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/807—Hapten conjugated with peptide or protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
AT98923421T 1997-05-14 1998-05-13 Schnelle bestimmung des verhältnisses von biologischen molekülen ATE302413T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4646797P 1997-05-14 1997-05-14
US4708197P 1997-05-19 1997-05-19
PCT/US1998/009836 WO1998052041A1 (en) 1997-05-14 1998-05-13 Rapid evaluation of the ratio of biological molecules

Publications (1)

Publication Number Publication Date
ATE302413T1 true ATE302413T1 (de) 2005-09-15

Family

ID=26723954

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98923421T ATE302413T1 (de) 1997-05-14 1998-05-13 Schnelle bestimmung des verhältnisses von biologischen molekülen

Country Status (7)

Country Link
US (2) US6670196B1 (de)
EP (1) EP0983509B1 (de)
AT (1) ATE302413T1 (de)
AU (1) AU7571998A (de)
CA (1) CA2290582C (de)
DE (1) DE69831229T2 (de)
WO (1) WO1998052041A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001276395A1 (en) * 2000-07-12 2002-02-05 Werner Naser Direct assessment of relative concentrations of variants of an epitope on a dimeric molecule
AU2001293699A1 (en) * 2000-07-12 2002-01-21 Werner Naser Direct assessment of analyte to reference molecule ratios
WO2002010760A1 (fr) * 2000-07-27 2002-02-07 Kyowa Medex Co., Ltd Technique relative a une epreuve d'immunite menee avec des particules d'un vehicule insoluble et reactif a cet effet
DE10211818B4 (de) * 2002-03-16 2006-07-06 peS Gesellschaft für medizinische Diagnose-Systeme mbH Verfahren zur quantitativen Bestimmung mehrerer Analyten
US20040132092A1 (en) * 2003-01-03 2004-07-08 Stetson Christopher M. Determining the density of functional moieties on polymer reagents
US7396689B2 (en) * 2005-02-04 2008-07-08 Decision Biomarkers Incorporated Method of adjusting the working range of a multi-analyte assay
WO2007053594A2 (en) * 2005-10-31 2007-05-10 Clontech Laboratories, Inc. Large dynamic range proteomic analysis methods and compositions for practicing the same
US8180572B2 (en) * 2007-10-25 2012-05-15 Canon U.S. Life Sciences, Inc. High-resolution melting analysis
EP2504466B1 (de) 2009-11-23 2019-11-20 Proxim Diagnostics Corporation Gesteuerte elektrochemische aktivierung von elektroden auf kohlenstoffbasis
US20110306148A1 (en) 2010-06-14 2011-12-15 Siemens Healthcare Diagnostics Inc. Composition for use as an assay reagent
WO2013015822A1 (en) 2011-07-25 2013-01-31 Mikhail Briman Cartridge for diagnostic testing
TWI480553B (zh) * 2011-08-15 2015-04-11 Univ Nat Cheng Kung 糖化血紅素之偵測方法
WO2016048388A1 (en) 2014-09-26 2016-03-31 Somalogic, Inc. Cardiovascular risk event prediction and uses thereof
EP4310184A3 (de) * 2018-02-23 2024-05-01 Meso Scale Technologies, LLC. Verfahren zum screenen von antigen-bindenden molekülen durch normalisierung auf die konzentration eines antigen-bindenden moleküls

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3935074A (en) 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US4690890A (en) * 1984-04-04 1987-09-01 Cetus Corporation Process for simultaneously detecting multiple antigens using dual sandwich immunometric assay
US4737453A (en) * 1984-12-12 1988-04-12 Immunomedics, Inc. Sandwich immunoassay utilizing a separation specific binding substance
US4806468A (en) 1987-02-05 1989-02-21 Becton, Dickinson And Company Measurement of glycosylated hemoglobin by immunoassay
GB8715282D0 (en) 1987-06-30 1987-08-05 Unilever Plc Analysis
US5429925A (en) * 1988-01-26 1995-07-04 The Regents Of The University Of California Method for immunodiagnostic detection of dioxins at low concentrations
US5028535A (en) 1989-01-10 1991-07-02 Biosite Diagnostics, Inc. Threshold ligand-receptor assay
SE9002480D0 (sv) * 1990-07-23 1990-07-23 Hans Lilja Assay of free and complexed prostate-specific antigen
CA2072758A1 (en) 1990-09-14 1992-03-15 Kenneth Francis Buechler Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays
US5196309A (en) * 1990-11-15 1993-03-23 The Scripps Research Institute Characterization of platelet aggregation disorders
US5506983A (en) * 1992-07-06 1996-04-09 Microsoft Corporation Method and system for transactioning of modifications to a tree structured file
US6455288B1 (en) 1993-04-08 2002-09-24 Dade Behring Marburg Gmbh Homogeneous immunoassays using mutant glucose-6-phosphate dehydrogenases
WO1995006877A1 (en) 1993-09-03 1995-03-09 Behringwerke Ag Fluorescent oxygen channeling immunoassays
AU1128195A (en) 1993-10-26 1995-05-22 Mayo Foundation For Medical Education And Research Direct fluorescence-conjugated immunoassay for platelet activation
US5599677A (en) * 1993-12-29 1997-02-04 Abbott Laboratories Immunoassays for prostate specific antigen
US5763199A (en) * 1994-09-29 1998-06-09 Mount Sinai School Of Medicine Of The City University Of New York Platelet blockade assay
US5795725A (en) * 1995-04-18 1998-08-18 Biosite Diagnostics Incorporated Methods for the assay of troponin I and T and selection of antibodies for use in immunoassays
US5947124A (en) * 1997-03-11 1999-09-07 Biosite Diagnostics Incorporated Diagnostic for determining the time of a heart attack

Also Published As

Publication number Publication date
CA2290582C (en) 2005-08-02
EP0983509B1 (de) 2005-08-17
US6670196B1 (en) 2003-12-30
US7202042B2 (en) 2007-04-10
DE69831229T2 (de) 2006-04-13
WO1998052041A1 (en) 1998-11-19
DE69831229D1 (de) 2005-09-22
AU7571998A (en) 1998-12-08
EP0983509A1 (de) 2000-03-08
US20040077026A1 (en) 2004-04-22
CA2290582A1 (en) 1998-11-19

Similar Documents

Publication Publication Date Title
ATE332368T1 (de) Selektion von proteinen mittels rns-protein fusionen
ATE302413T1 (de) Schnelle bestimmung des verhältnisses von biologischen molekülen
EP1687283A4 (de) Für die bestimmung von fk506 geeignetes verfahren und zusammensetzung
DE69707029D1 (de) Karaokevorrichtung mit angepasstem Potpourri erhalten durch das miteinander Verbinden von verschiedenen Musikstücken
DE60029572D1 (de) Isolierung und analyse von proteinen
ATE439592T1 (de) Proteingerüste für antikörper-nachahmer und andere bindende proteine
DE69828625D1 (de) Reagenzien und methoden zur bindung von zielmolekülen an eine oberfläche
DE59903915D1 (de) Verfahren zur frühen diagnose von carcinomen
DE69823214D1 (de) Kit zur Längenbestimmung von Kathetern vor ihrer Einführung
EP1049808A4 (de) Test zur bestimmung von kraftdiskriminierung
ATE397251T1 (de) Verfahren für das entwerfen von kleinen erythropoietin mimetika
HUT77049A (hu) Katepszin-02-fehérjék, -nukleinsavak és -ellenanyagok
ATE148923T1 (de) Funktioneller test und reagenz zur bestimmung von fibrinogen
DE69622776D1 (de) Von Multitasking gebrauch machendes Sortieren
DE69522579D1 (de) Verwendung von spezifische lipolytische enzyme in reinigungsmitteln
DE60133558D1 (de) Direkte bestimmung des quotients von analyt- zu referenzmolekülen
DE59712537D1 (de) Messanordnung zur bestimmung von gasbestandteilen in gasgemischen
DE69220080D1 (de) Reagenzzusammensetzung in form von benutzer-einheiten für spezifische bindungstests
DE69737476D1 (de) Neuer galaninrezeptor
DE69730451D1 (de) Kassette zur aufnahme von flachen artikeln
EP1253934A4 (de) Methoden zur bestimmung des risikos von gebärmutterhalskrebsentwicklung
DE69717631D1 (de) Bestimmung von teilchenförmigen verunreinigungen
FI901680A7 (fi) Entsyymiluminesenssianalyysi
DE69725830D1 (de) Prozessor für Information in Form von Zeichen
DE69709485D1 (de) Reagenszusammensetzung, Teststück und Testkit

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties